Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastrointest Oncol. Oct 15, 2014; 6(10): 413-419
Published online Oct 15, 2014. doi: 10.4251/wjgo.v6.i10.413
Published online Oct 15, 2014. doi: 10.4251/wjgo.v6.i10.413
Figure 1 Enzyme linked immuno-absorbent assay determined preoperative plasma monocyte chemotactic protein-1 levels of patients in the benign and malignant group.
Monocyte chemotactic protein-1 (MCP-1) levels are expressed as median and CI. [PreOp Benign (n = 86) vs PreOp Cancer (n = 102), bP = 0.0004]. PreOp: Preoperative; BEN: Benign disease; CRC: Colorectal cancer.
Figure 2 Enzyme linked immuno-absorbent assay determined preoperative and postoperative monocyte chemotactic protein-1 levels of colorectal cancer patients.
Monocyte chemotactic protein-1 (MCP-1) levels are expressed as expressed as median and 75% quartile range [PreOp vs POD 1 (n = 102), PreOp vs POD 3 (n = 100), PreOp vs POD 7-13 (n = 61), PreOp vs POD 14 -20 (n = 27), PreOp vs POD 21-27 (n = 28), bP < 0.001]. PreOp: Preoperative; POD: Postoperative day.
- Citation: Kumara HS, Myers EA, Herath SA, Jang JH, Njoh L, Yan X, Kirchoff D, Cekic V, Luchtefeld M, Whelan RL. Plasma monocyte chemotactic protein-1 remains elevated after minimally invasive colorectal cancer resection. World J Gastrointest Oncol 2014; 6(10): 413-419
- URL: https://www.wjgnet.com/1948-5204/full/v6/i10/413.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v6.i10.413